Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Mar 1;2(3):e191540.
doi: 10.1001/jamanetworkopen.2019.1540.

Association of Diabetic Retinopathy and Diabetic Kidney Disease With All-Cause and Cardiovascular Mortality in a Multiethnic Asian Population

Charumathi Sabanayagam  1   2 , Miao Li Chee  1 , Riswana Banu  1 , Ching-Yu Cheng  1   2 , Su Chi Lim  3 , E Shyong Tai  4 , Thomas Coffman  5 , Tien Y Wong  1   2
Affiliations

Association of Diabetic Retinopathy and Diabetic Kidney Disease With All-Cause and Cardiovascular Mortality in a Multiethnic Asian Population

Charumathi Sabanayagam et al. JAMA Netw Open. .

Abstract

Importance: The association of diabetic microvascular complications such as diabetic retinopathy (DR) and diabetic kidney disease (DKD) with mortality in populations is not clear.

Objective: To examine the association of DR and DKD separately and jointly with all-cause and cardiovascular disease (CVD) mortality in a multiethnic Asian population.

Design, setting, and participants: A population-based cohort study was conducted including 2964 adults between the ages of 40 and 80 years with diabetes who participated in the Singapore Epidemiology of Eye Diseases study (baseline, 2004-2011). Data analysis was performed from January to May 2018.

Exposures: Diabetic retinopathy ascertained from retinal photographs and DKD from estimated glomerular filtration rate.

Main outcomes and measures: All-cause and CVD mortality obtained by linkage with the National Registry of Births and Deaths until May 2017.

Results: Of the 2964 adults (mean [SD] age, 61.8 [10.0] years; 1464 [49.4%] female; 592 Chinese, 1052 Malay, and 1320 Indian), 29.9% of the participants had DR, while 20.7% had DKD. Over a median (interquartile range) follow-up of 8.8 (7.2-11.0) years, 610 deaths occurred (20.6%), of which 267 (9.0%) were due to CVD. In separate models, the multivariable hazard ratios for all-cause and CVD mortality were 1.54 (95% CI, 1.24-1.91) and 1.74 (95% CI, 1.27-2.40), respectively, for DR and 2.04 (95% CI, 1.64-2.56) and 2.29 (95% CI, 1.64-3.19), respectively, for DKD. In models including both DR and DKD, the subgroup with DKD alone (27.1% and 12.6%) followed by DR alone (6.5% and 5.2%) contributed substantially to the excess risk of all-cause and CVD mortality. Compared with those with no DR and DKD, the hazard ratios of all-cause and CVD mortality were 1.89 (95% CI, 1.40-2.57) and 2.26 (95% CI, 1.42-3.61), respectively, for DKD alone and 1.38 (95% CI, 1.03-1.86) and 1.64 (95% CI, 1.06-2.56), respectively, for DR alone. Hazard ratios for all-cause and CVD mortality were 2.76 (95% CI, 2.05-3.72) and 3.41 (95% CI, 2.19-5.32), respectively, for those with both DKD and DR. The relative excess risk associated with the interaction was 0.49 (95% CI, -0.29 to 1.27; P = .20) for all-cause mortality and 0.51 (95% CI, -0.83 to 1.85; P = .50) for CVD mortality.

Conclusions and relevance: These results suggest that risks of all-cause and CVD mortality were significantly higher in those with DKD and DR, but DKD was more strongly associated with excess risk. The findings underscore the importance of early identification and close monitoring and management of patients with DR and DKD to reduce the risk of death.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Disclosures: Dr Wong reported personal fees from Allergan, Bayer, Boehringer Ingelheim, Genentech, Merck, Novartis, Oxurion (formerly ThromboGenics), and Roche outside the submitted work; and serving as cofounder of plano and EyRiS. No other disclosures were reported.

Figures

Figure 1.
Figure 1.. Joint Association of Diabetic Retinopathy (DR) and Diabetic Kidney Disease (DKD) With All-Cause and Cardiovascular Disease (CVD) Mortality
Figure 2.
Figure 2.. Additive Interaction of Diabetic Retinopathy (DR) and Diabetic Kidney Disease (DKD) on Absolute All-Cause and Cardiovascular Disease (CVD) Mortality Rates
See this image and copyright information in PMC

References

    1. Ogurtsova K, da Rocha Fernandes JD, Huang Y, et al. . IDF Diabetes Atlas: global estimates for the prevalence of diabetes for 2015 and 2040. Diabetes Res Clin Pract. 2017;128:-. doi:10.1016/j.diabres.2017.03.024 - DOI - PubMed
    1. Rao Kondapally Seshasai S, Kaptoge S, Thompson A, et al. ; Emerging Risk Factors Collaboration . Diabetes mellitus, fasting glucose, and risk of cause-specific death. N Engl J Med. 2011;364(9):829-841. doi:10.1056/NEJMoa1008862 - DOI - PMC - PubMed
    1. Röckl S, Brinks R, Baumert J, et al. . All-cause mortality in adults with and without type 2 diabetes: findings from the national health monitoring in Germany. BMJ Open Diabetes Res Care. 2017;5(1):e000451. doi:10.1136/bmjdrc-2017-000451 - DOI - PMC - PubMed
    1. Nichols GA, Déruaz-Luyet A, Hauske SJ, Brodovicz KG. The association between estimated glomerular filtration rate, albuminuria, and risk of cardiovascular hospitalizations and all-cause mortality among patients with type 2 diabetes. J Diabetes Complications. 2018;32(3):291-297. doi:10.1016/j.jdiacomp.2017.12.003 - DOI - PubMed
    1. Salinero-Fort MA, San Andrés-Rebollo FJ, de Burgos-Lunar C, et al. ; MADIABETES Group . Cardiovascular and all-cause mortality in patients with type 2 diabetes mellitus in the MADIABETES Cohort Study: association with chronic kidney disease. J Diabetes Complications. 2016;30(2):227-236. doi:10.1016/j.jdiacomp.2015.10.007 - DOI - PubMed

Publication types